Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Jan;52(1):153–160. doi: 10.1172/JCI107159

Pathogenesis of Hypocalcemia in Primary Hypomagnesemia: Normal End-Organ Responsiveness to Parathyroid Hormone, Impaired Parathyroid Gland Function

Se Mo Suh 1,2,3,4, Armen H Tashjian Jr 1,2,3,4, Nobutake Matsuo 1,2,3,4, David K Parkinson 1,2,3,4, Donald Fraser 1,2,3,4
PMCID: PMC302237  PMID: 4345201

Abstract

Hypocalcemia is a frequent feature of hypomagnesemia in man and several other species. To elucidate the cause of this hypocalcemia, we have studied a child with primary hypomagnesemia and secondary hypocalcemia during magnesium supplementation when he was normomagnesemic and normocalcemic and after magnesium restriction for 16 days when he quickly became hypomagnesemic (0.5 meq/liter) and hypocalcemic (3.4 meq/liter) and had positive Chvostek's and Trousseau's signs.

Whether in the normomagnesemic or hypomagnesemic state, intravenous bovine parathyroid extract (PTE) 8 U. S. P. U/kg promptly caused transient increases in the urinary phosphate excretion, renal phosphate clearance and cyclic AMP excretion. The magnitudes of these responses were similar in the two states, and similar to those observed in a hypoparathyroid patient. When the patient was hypomagnesemic and hypocalcemic, intramuscular PTE, 8 U/kg at 8-h intervals for four doses promptly caused hypercalcemia. The findings indicate that the end-organs were responsive to parathyroid hormone.

The concentrations of serum parathyroid hormone (PTH) were normal in the normomagnesemic state ranging from 0.15 ng/ml to 0.40 ng/ml. Serum PTH did not increase in the hypomagnesemic state in spite of hypocalcemia. Indeed, PTH became unmeasurable in four consecutive samples at the end of the period of magnesium restriction.

The concentrations of serum calcitonin remained unmeasurable (< 0.10 ng/ml) throughout the study, implying that excess calcitonin was not the cause of hypocalcemia in magnesium depletion.

The findings in this study support our thesis that magnesium depletion causes impaired synthesis or secretion of parathyroid hormone. This impairment would account for the hypocalcemia observed in the hypomagnesemic state.

Full text

PDF
153

Images in this article

156Image
on p.156
157Image
on p.157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anast C. S., Mohs J. M., Kaplan S. L., Burns T. W. Evidence for parathyroid failure in magnesium deficiency. Science. 1972 Aug 18;177(4049):606–608. doi: 10.1126/science.177.4049.606. [DOI] [PubMed] [Google Scholar]
  2. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dunn M. J. Magnesium depletion in the rhesus monkey: induction of magnesium-dependent hypocalcaemia. Clin Sci. 1971 Oct;41(4):333–344. doi: 10.1042/cs0410333. [DOI] [PubMed] [Google Scholar]
  4. Estep H., Shaw W. A., Watlington C., Hobe R., Holland W., Tucker S. G. Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. J Clin Endocrinol Metab. 1969 Jun;29(6):842–848. doi: 10.1210/jcem-29-6-842. [DOI] [PubMed] [Google Scholar]
  5. HEATON F. W. THE PARATHYROID GLANDS AND MAGNESIUM METABOLISM IN THE RAT. Clin Sci. 1965 Jun;28:543–553. [PubMed] [Google Scholar]
  6. Hahn T. J., Chase L. R., Avioli L. V. Effect of magnesium depletion on responsiveness to parathyroid hormone in parathyroidectomized rats. J Clin Invest. 1972 Apr;51(4):886–891. doi: 10.1172/JCI106883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaminsky N. I., Broadus A. E., Hardman J. G., Jones D. J., Jr, Ball J. H., Sutherland E. W., Liddle G. W. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest. 1970 Dec;49(12):2387–2395. doi: 10.1172/JCI106458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MacManus J., Heaton F. W., Lucas P. W. A decreased response to parathyroid hormone in magnesium deficiency. J Endocrinol. 1971 Feb;49(2):253–258. doi: 10.1677/joe.0.0490253. [DOI] [PubMed] [Google Scholar]
  9. MacManus J., Heaton F. W. The effect of magnesium deficiency on calcium homeostasis in the rat. Clin Sci. 1969 Apr;36(2):297–306. [PubMed] [Google Scholar]
  10. Melvin K. E., Miller H. H., Tashjian A. H., Jr Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med. 1971 Nov;285(20):1115–1120. doi: 10.1056/NEJM197111112852004. [DOI] [PubMed] [Google Scholar]
  11. Melvin K. E., Tashjian A. H., Jr, Miller H. H. Studies in familial (medullary) thyroid carcinoma. Recent Prog Horm Res. 1972;28:399–470. [PubMed] [Google Scholar]
  12. Muldowney F. P., McKenna T. J., Kyle L. H., Freaney R., Swan M. Parathormone-like effect of magnesium replenishment in steatorrhea. N Engl J Med. 1970 Jan 8;282(2):61–68. doi: 10.1056/NEJM197001082820203. [DOI] [PubMed] [Google Scholar]
  13. Murad F., Pak C. Y. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. N Engl J Med. 1972 Jun 29;286(26):1382–1387. doi: 10.1056/NEJM197206292862604. [DOI] [PubMed] [Google Scholar]
  14. Paunier L., Radde I. C., Kooh S. W., Conen P. E., Fraser D. Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics. 1968 Feb;41(2):385–402. [PubMed] [Google Scholar]
  15. Rojo-Ortega J. M., Brecht H. M., Genest J. Effects of magnesium-deficient diet on the thyroid C cells and parathyroid gland of the dog. Virchows Arch B Cell Pathol. 1971;7(2):81–89. doi: 10.1007/BF02892081. [DOI] [PubMed] [Google Scholar]
  16. Skyberg D., Stromme J. H., Nesbakken R., Harnaes K. Neonatal hypomagnesemia with selective malabsorption of magnesium--a clinical entity. Scand J Clin Lab Invest. 1968;21(4):355–363. doi: 10.3109/00365516809077007. [DOI] [PubMed] [Google Scholar]
  17. Stromme J. H., Nesbakken R., Normann T., Skjorten F., Skyberg D., Johannessen B. Familial hypomagnesemia. Biochemical, histological and hereditary aspects studied in two brothers. Acta Paediatr Scand. 1969 Sep;58(5):433–444. doi: 10.1111/j.1651-2227.1969.tb04743.x. [DOI] [PubMed] [Google Scholar]
  18. Suh S. M., Csima A., Fraser D. Pathogenesis of hypocalcemia in magnesium depletion. Normal end-organ responsiveness to parathyroid hormone. J Clin Invest. 1971 Dec;50(12):2668–2678. doi: 10.1172/JCI106768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tashijan A. H., Jr, Howland B. G., Melvin K. E., Hill C. S., Jr Immunoassay of human calcitonin. N Engl J Med. 1970 Oct 22;283(17):890–895. doi: 10.1056/NEJM197010222831702. [DOI] [PubMed] [Google Scholar]
  20. Tashjian A. H., Jr, Frantz A. G., Lee J. B. Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1138–1142. doi: 10.1073/pnas.56.4.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Taylor A. L., Davis B. B., Pawlson L. G., Josimovich J. B., Mintz D. H. Factors influencing the urinary excretion of 3',5'-adenosine monophosphate in humans. J Clin Endocrinol Metab. 1970 Mar;30(3):316–324. doi: 10.1210/jcem-30-3-316. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES